UCB SA (UCB) - Medical Equipment - Deals and Alliances Profile.
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The companys key medicines include Cimzia for ankylosing spondylitis, axial spondylarthritis, Crohns disease, psoriatic arthritis and rheumatoid arthritis; Neupro for Parkinsons disease and restless legs syndrome; and Vimpat, Keppra and Briviact for epilepsy. UCB is also developing new therapies for neurological and immunological diseases. The company operates subsidiaries in the US, Japan, China, Germany, Italy, Spain, France, the UK, Ireland, Belgium, Brazil, Russia, India, Mexico, Turkey and other countries. UCB is headquartered in Brussels, Belgium.
UCB SA (UCB) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The companys key medicines include Cimzia for ankylosing spondylitis, axial spondylarthritis, Crohns disease, psoriatic arthritis and rheumatoid arthritis; Neupro for Parkinsons disease and restless legs syndrome; and Vimpat, Keppra and Briviact for epilepsy. UCB is also developing new therapies for neurological and immunological diseases. The company operates subsidiaries in the US, Japan, China, Germany, Italy, Spain, France, the UK, Ireland, Belgium, Brazil, Russia, India, Mexico, Turkey and other countries. UCB is headquartered in Brussels, Belgium.
UCB SA (UCB) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 3
List of Figures 4
UCB SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
UCB SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
UCB SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
UCB SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
UCB SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
UCB SA, Medical Equipment, Deal Details 10
Partnerships 10
MC10 Enters into Agreement with UCB 10
Evogen Enters into Agreement with UCB 10
MC10 Enters into Co-Development Agreement with UCB 11
Allium Medical Solutions Enters Into Distribution Agreement With Meizler UCB Biopharma For Urological Stents 11
OTR3 Enters Into Distribution Agreement With UCB For Cacipliq20 12
Kings College London Enters Into Licensing Agreement with UCB 13
Acquisition 14
UCB Acquires 51% Stake In Meizler Biopharma 14
UCB SA - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 23
Strategy And Business Planning 23
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery 23
Financial Announcements 24
Apr 24, 2017: UCB First Three Months Interim Report 2017: UCB with a good start into 2017 24
Jul 27, 2016: UCB continues to deliver on its growth strategy 25
Apr 25, 2016: UCB First Three Months Interim Report 2016 26
Feb 26, 2016: UCB with progress on its growth path delivering value to patients and shareholders 27
Corporate Communications 29
Mar 24, 2017: UCB General Meeting on 27 April 2017 29
Dec 15, 2016: New appointments on UCBs Board of Directors 30
Mar 25, 2016: Nominations for new members of UCBs Board of Directors 31
Jan 15, 2016: UCBs Executive Committee welcomes a new member 32
Other Significant Developments 33
Apr 26, 2017: UCB Selects Medidata Clinical Cloud to Support Patient-Centric Drug Development 33
Jan 05, 2017: MC10 and UCB Complete Landmark Pharmaceutical / Technology Collaboration Evaluating Patient Monitoring in Parkinsons 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List Of Tables
UCB SA, Medical Equipment, Key Facts, 2016 1
UCB SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
UCB SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
UCB SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
UCB SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
UCB SA, Deals By Market, 2011 to YTD 2017 8
UCB SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
MC10 Enters into Agreement with UCB 10
Evogen Enters into Agreement with UCB 10
MC10 Enters into Co-Development Agreement with UCB 11
Allium Medical Solutions Enters Into Distribution Agreement With Meizler UCB Biopharma For Urological Stents 11
OTR3 Enters Into Distribution Agreement With UCB For Cacipliq20 12
Kings College London Enters Into Licensing Agreement with UCB 13
UCB Acquires 51% Stake In Meizler Biopharma 14
UCB SA, Key Competitors 16
UCB SA, Key Employees 17
UCB SA, Subsidiaries 19
List Of Figures
UCB SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
UCB SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
UCB SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
UCB SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
UCB SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
UCB SA, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
UCB SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
UCB SA, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
RELATED REPORTS
UCB SA (UCB) - Financial and Strategic SWOT Analysis Review
UCB SA (UCB) - Financial and Strategic SWOT Analysis Review
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
